Connect Biopharma Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Dec 23 | SellUS$750,285 | RA Capital Management, L.P. | Company | 830,702 | US$1.00 | |
04 Dec 23 | SellUS$1,336,284 | RA Capital Management, L.P. | Company | 1,035,992 | US$1.57 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,306,149 | 9.63% |
Institutions | 7,426,472 | 13.5% |
General Public | 8,622,688 | 15.6% |
Individual Insiders | 12,143,062 | 22% |
VC/PE Firms | 21,603,083 | 39.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
12,000,000 | US$23.4m | 100% | 43.39% | |||
6,197,398 | US$12.1m | 4.55% | no data | |||
5,928,164 | US$11.6m | 0% | no data | |||
5,306,149 | US$10.3m | 0% | no data | |||
4,840,898 | US$9.4m | 0% | 0.77% | |||
4,762,185 | US$9.3m | 0% | no data | |||
2,124,605 | US$4.1m | 0% | 0.52% | |||
2,061,338 | US$4.0m | 0% | 1.95% | |||
1,212,302 | US$2.4m | 0% | no data | |||
1,040,067 | US$2.0m | 0% | no data | |||
561,191 | US$1.1m | -7.07% | 0.07% | |||
298,000 | US$581.1k | 207% | no data | |||
27,961 | US$54.5k | 46.9% | no data | |||
20,000 | US$39.0k | 0% | no data | |||
19,700 | US$38.4k | 75.9% | 0.01% | |||
16,520 | US$32.2k | 0% | no data | |||
14,778 | US$28.8k | 0% | no data | |||
12,307 | US$24.0k | 0% | no data | |||
11,405 | US$22.2k | -33.8% | no data | |||
10,000 | US$19.5k | 0% | no data | |||
7,500 | US$14.6k | 200% | no data | |||
3,078 | US$6.0k | 0% | no data | |||
2,500 | US$4.9k | 0% | no data | |||
449 | US$870.3 | 76.1% | no data | |||
121 | US$236.4 | 0% | no data |